Search Results - "Warnke, Clemens"

A systematic review of neurological symptoms and complications of COVID-19 by Chen, Xiangliang, Laurent, Sarah, Onur, Oezguer A., Kleineberg, Nina N., Fink, Gereon R., Schweitzer, Finja, Warnke, Clemens

“…Objective To study the frequency of neurological symptoms and complications in COVID-19 patients in a systematic review of the literature. Methods Relevant…”
Get full text

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry by Ohle, Lisa-Marie, Ellenberger, David, Flachenecker, Peter, Friede, Tim, Haas, Judith, Hellwig, Kerstin, Parciak, Tina, Warnke, Clemens, Paul, Friedemann, Zettl, Uwe K., Stahmann, Alexander

“…In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare…”
Get full text

Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression by Proschinger, Sebastian, Kuhwand, Puya, Rademacher, Annette, Walzik, David, Warnke, Clemens, Zimmer, Philipp, Joisten, Niklas

“…Background A moderate to high level of physical activity, including regular exercise, represents an established behavioral and rehabilitative approach for…”
Get full text

Immunological Aspects of Approved MS Therapeutics by Rommer, Paulus S, Milo, Ron, Han, May H, Satyanarayan, Sammita, Sellner, Johann, Hauer, Larissa, Illes, Zsolt, Warnke, Clemens, Laurent, Sarah, Weber, Martin S, Zhang, Yinan, Stuve, Olaf

“…Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading to disability in young adults. The outcome of the disease is…”
Get full text

High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation by Joisten, Niklas, Proschinger, Sebastian, Rademacher, Annette, Schenk, Alexander, Bloch, Wilhelm, Warnke, Clemens, Gonzenbach, Roman, Kool, Jan, Bansi, Jens, Zimmer, Philipp

“…In persons with multiple sclerosis (PwMS), the neutrophil-to-lymphocyte ratio (NLR) is associated with disability status, symptomatology and disease activity…”
Get full text

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy by Möhn, Nora, Grote-Levi, Lea, Hopfner, Franziska, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Warnke, Clemens, Sühs, Kurt-Wolfram, Wattjes, Mike P., Höglinger, Günter U., Skripuletz, Thomas

“…Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral disease of the brain—caused by human polyomavirus 2. It affects patients whose…”
Get full text

Big data in MS—What can we learn from large international observational studies such as MSBase? by Warnke, Clemens, Hartung, Hans-Peter

Get full text

Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest by Adler, Christoph, Onur, Oezguer A., Braumann, Simon, Gramespacher, Hannes, Bittner, Stefan, Falk, Steffen, Fink, Gereon R., Baldus, Stephan, Warnke, Clemens

“…Objectives To test if the early kinetics of neurofilament light (NFL) in blood adds to the absolute values of NFL in the prediction of outcome, and to evaluate…”
Get full text

Application of “Mentzer’s PML case definition” to natalizumab-treated patients in the setting of strict MRI-based pharmacovigilance by Wijburg, Martijn T., Warnke, Clemens, Killestein, Joep, Wattjes, Mike P.

“…Objective To compare the available diagnostic criteria for progressive multifocal leukoencephalopathy (PML) diagnosis in a real-world cohort of patients with…”
Get full text

Challenging a concept: Pulsed treatment regimen—No risk of PML? by Warnke, Clemens, Hartung, Hans-Peter

Get full text

Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage by Boesl, Fabian, Goereci, Yasemin, Schweitzer, Finja, Finke, Carsten, Schild, Ann-Katrin, Bittner, Stefan, Steffen, Falk, Schröder, Maria, Quitschau, Anneke, Heine, Josephine, Warnke, Clemens, Franke, Christiana

“…Cognitive impairment is the most frequent symptom reported in post-COVID-19 syndrome (PCS). Aetiology of cognitive impairment in PCS is still to be determined…”
Get full text

Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry by Blaschke, Stefan J, Ellenberger, David, Flachenecker, Peter, Hellwig, Kerstin, Paul, Friedemann, Pöhlau, Dieter, Kleinschnitz, Christoph, Rommer, Paulus S, Rueger, Maria A, Zettl, Uwe K, Stahmann, Alexander, Warnke, Clemens

“…Objective: To investigate the time to diagnosis in multiple sclerosis (MS) in Germany. Methods: Analysis of real-world registry data from the German Multiple…”
Get full text

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients by Schwab, Nicholas, Schneider-Hohendorf, Tilman, Posevitz, Vilmos, Breuer, Johanna, Göbel, Kerstin, Windhagen, Susanne, Brochet, Bruno, Vermersch, Patrick, Lebrun-Frenay, Christine, Posevitz-Fejfár, Anita, Capra, Ruggero, Imberti, Luisa, Straeten, Vera, Haas, Juergen, Wildemann, Brigitte, Havla, Joachim, Kümpfel, Tania, Meinl, Ingrid, Niessen, Kyle, Goelz, Susan, Kleinschnitz, Christoph, Warnke, Clemens, Buck, Dorothea, Gold, Ralf, Kieseier, Bernd C., Meuth, Sven G., Foley, John, Chan, Andrew, Brassat, David, Wiendl, Heinz

“…OBJECTIVE:To find biomarkers identifying patients at risk for the development of progressive multifocal leukoencephalopathy (PML) during natalizumab treatment…”
Get full text

Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study) by Hümmert, Martin W, Stern, Carlotta, Paul, Friedemann, Duchow, Ankelien, Bellmann-Strobl, Judith, Ayzenberg, Ilya, Schwake, Carolin, Kleiter, Ingo, Hellwig, Kerstin, Jarius, Sven, Wildemann, Brigitte, Senel, Makbule, Berthele, Achim, Giglhuber, Katrin, Luessi, Felix, Grothe, Matthias, Klotz, Luisa, Schülke, Rasmus, Gingele, Stefan, Faiss, Jürgen H, Walter, Annette, Warnke, Clemens, Then Bergh, Florian, Aktas, Orhan, Ringelstein, Marius, Stellmann, Jan-Patrick, Häußler, Vivien, Havla, Joachim, Pellkofer, Hannah, Kümpfel, Tania, Kopp, Bruno, Trebst, Corinna

“…Background: There is limited and inconsistent information on the prevalence of cognitive impairment in neuromyelitis optica spectrum disorders (NMOSD)…”
Get full text

A Network Perspective on Neuropsychiatric and Cognitive Symptoms of the Post-COVID Syndrome by Scharfenberg, Daniel, Schild, Ann-Katrin, Warnke, Clemens, Maier, Franziska

“…Many patients that were infected with SARS-CoV-2 experience cognitive and affective symptoms weeks and months after their acute COVID-19 disease, even when…”
Get full text

EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseases by von Martial, Sophia, Brix, Tobias J, Klotz, Luisa, Neuhaus, Philipp, Berger, Klaus, Warnke, Clemens, Meuth, Sven G, Wiendl, Heinz, Dugas, Martin

“…Although routine health care and clinical trials usually require the documentation of similar information, data collection is performed independently from each…”
Get full text

"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study by Müller, Anne, Hebben, Fabian, Dillen, Kim, Dunkl, Veronika, Goereci, Yasemin, Voltz, Raymond, Löcherbach, Peter, Warnke, Clemens, Golla, Heidrun

“…Persons with severe Multiple Sclerosis (PwsMS) face complex needs and daily limitations that make it challenging to receive optimal care. The implementation…”
Get full text

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations by Stahmann, Alexander, Craig, Elaine, Ellenberger, David, Fneish, Firas, Frahm, Niklas, Marrie, Ruth Ann, Middleton, Rod, Nicholas, Richard, Rodgers, Jeff, Warnke, Clemens, Salter, Amber

“…Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies…”
Get full text

Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination by Goereci, Yasemin, Kleineberg, Nina N., Madlener, Marie, Neuschmelting, Hannah, Fink, Gereon R., Warnke, Clemens, Stetefeld, Henning

“…Abstract The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by infection with SARS-CoV-2 has been associated with…”
Get full text

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results by Link, Jenny, Ramanujam, Ryan, Auer, Michael, Ryner, Malin, Hässler, Signe, Bachelet, Delphine, Mbogning, Cyprien, Warnke, Clemens, Buck, Dorothea, Hyldgaard Jensen, Poul Erik, Sievers, Claudia, Ingenhoven, Kathleen, Fissolo, Nicolas, Lindberg, Raija, Grummel, Verena, Donnellan, Naoimh, Comabella, Manuel, Montalban, Xavier, Kieseier, Bernd, Soelberg Sørensen, Per, Hartung, Hans-Peter, Derfuss, Tobias, Lawton, Andy, Sikkema, Dan, Pallardy, Marc, Hemmer, Bernhard, Deisenhammer, Florian, Broët, Philippe, Dönnes, Pierre, Davidson, Julie, Fogdell-Hahn, Anna

“…Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in several…”
Get full text